Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on the day's biggest business stories

Subscribe to Axios Closer for insights into the day’s business news and trends and why they matter

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Stay on top of the latest market trends

Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Axios on your phone

Get breaking news and scoops on the go with the Axios app.

Download for free.

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sign up for Axios NW Arkansas

Stay up-to-date on the most important and interesting stories affecting NW Arkansas, authored by local reporters

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Photo: Chip Somodevilla/Getty Images

President Biden on Thursday announced a new COVID-19 vaccine goal at his first press conference since taking office: 200 million shots administered within his first 100 days.

Why it matters ... At the current 7-day average of about 2.5 million doses administered per day, the U.S. would reach 200 million shots in the days leading up to Biden's 100th day in office: April 30.

  • The U.S. easily surpassed Biden's original goal of 100 million shots in his first 100 days, which some criticized as insufficiently ambitious.
  • The president is now significantly increasing expectations, with the U.S. having administered roughly 115 million doses through his first 64 days, according to Bloomberg.

What they're saying: "I know it's ambitious, twice our original goal, but no other country in the world is going to come close, not even close, to what we are doing," Biden said at the outset of his first news conference, before taking questions.

Between the lines: Since Biden took office, the Johnson & Johnson one-shot vaccine has been authorized for use by the FDA, providing a third option to a national stockpile that already included the Pfizer and Moderna vaccines.

  • With states having had several few months to work out kinks in their vaccine systems, the U.S. has reached record highs of over 3 million doses administered
  • Biden has ordered all states to make coronavirus vaccines to all adults by May 1, and dozens have already met that eligibility goal.

Yes, but: The massive scale and complexity of the vaccine rollout could bring hurdles that slow the current pace of distribution, such as a drop in demand, logistical issues, or unforeseen supply problems.

The big picture: The president is aiming for Americans to be able to gather safely in small groups by July 4. The Centers for Disease Control has said that fully vaccinated people can gather indoors — without masks — and still be safe.

This story is breaking news. Please check back for updates.

Go deeper

Coronavirus cases rise in 19 states

Expand chart
Data: CSSE Johns Hopkins University; Map: Andrew Witherspoon/Axios

New coronavirus infections rose over the past week in 19 states while holding steady nationwide.

The big picture: The U.S. is in a race to vaccinate as many Americans as possible before variants of COVID-19, fueled by quick reopening, can cause a new wave of rising caseloads.

Mar 25, 2021 - Health

Over 40 states set to expand vaccine eligibility to all adults by May 1

Illustration: Brendan Lynch/Axios

More than 40 states plan to meet President Biden's goal of making all adults eligible for the coronavirus vaccine by May 1, and at least 30 plan to open up eligibility before then, per NYT.

What they're saying: "My thought is that we're going to see a continued decrease in transmission as we open vaccine eligibility," Cindy Prins, an epidemiologist at the University of Florida, told NYT.

Mar 25, 2021 - World

India pauses vaccine exports amid surge in cases

Waiting for vaccines in New Delhi. Photo: Sonu Mehta/Hindustan Times via Getty

Exports of the Oxford/AstraZeneca vaccine from the world's largest vaccine manufacturer, the Serum Institute of India, have been paused as India grapples with a new spike in cases, Reuters reports.

Why it matters: India hasn't exported any doses at all over the past week, according to foreign ministry data — a worrying sign for the COVAX initiative, which aims to send vaccines all over the world and is relying heavily on Indian-made vaccines.